NClip

Obesity

4 min read

Obesity

Key Points

  • Obesity is chronic excess adipose accumulation from sustained positive energy balance and is an excess-malnutrition state.
  • Risk is shaped by behavior, genetics, medication and illness burden, sleep dysregulation, and social determinants of health.
  • BMI and waist circumference are key screening tools, but BMI alone can miss body-composition and ethnicity-specific risk.
  • Nursing priorities include individualized assessment, realistic behavior-change goals, psychosocial support, and long-term adherence coaching.
  • Treatment pathways include lifestyle intervention, selected anti-obesity medications, and bariatric surgery for qualifying high-risk profiles.

Pathophysiology

Obesity develops when caloric intake persistently exceeds energy expenditure. Excess glucose and other substrates are converted to glycogen and fatty acids, then stored in adipose tissue. Over time, this promotes progressive adiposity and cardiometabolic risk.

Central appetite and satiety signaling involves hypothalamic pathways and hormones such as leptin and ghrelin. Sleep disruption, chronic stress, and sedentary behavior can shift these pathways toward increased hunger and reduced satiety, reinforcing overeating patterns.

Classification

  • BMI pattern: Obesity is typically BMI >=30; severe obesity is commonly BMI >=40.
  • Class pattern: Class I 30-34.9, class II 35-39.9, class III >=40.
  • Ethnicity-adjusted pattern: In many Asian and South Asian populations, risk thresholds are lower (overweight 23-24.9, obesity >=25).
  • Central-adiposity pattern: Waist circumference adds high-risk information (commonly >40 inches in males and >35 inches in females).

Nursing Assessment

NCLEX Focus

Prioritize obesity-related risk clustering and readiness for sustained change, not short-term weight targets alone.

  • Assess weight history, prior weight-loss attempts, sleep pattern, physical-activity level, eating pattern, and psychosocial stressors.
  • Assess social determinants affecting nutrition and activity access, including affordability, community safety, and support systems.
  • Measure and trend height, weight, BMI, and waist circumference using consistent technique.
  • Assess obesity-related comorbid patterns, including hypertension, diabetes, dyslipidemia, sleep apnea, mood symptoms, and mobility limits.
  • Review medication and illness contributors that can increase weight.
  • Support diagnostics ordered for risk-stratification (for example metabolic panel, lipid profile, hemoglobin A1c, thyroid studies, liver/kidney studies, and sleep-study referral when indicated).

Nursing Interventions

  • Use collaborative, realistic goals with staged lifestyle change rather than rapid unsustainable targets.
  • Reinforce nutrition strategies: portion control, meal scheduling, lower-calorie substitutions, and food-diary tracking.
  • Promote activity plans matched to function and comorbidity status, with progression over time.
  • Use motivational interviewing and nonstigmatizing language to support adherence and self-efficacy.
  • Coordinate interdisciplinary care with dietitian, behavioral-health support, endocrinology, and bariatric team when indicated.
  • Reassess outcomes at defined intervals and revise the care plan when adherence barriers or adverse effects emerge.

Bariatric Surgery Considerations

  • Typical candidacy includes BMI >=40 or BMI >=35 with significant obesity-related comorbidity.
  • Common procedures include vertical sleeve gastrectomy and Roux-en-Y gastric bypass.
  • Monitor for postoperative complications and deficiencies (for example reflux, stricture, ulcer risk with NSAID/smoking exposure, dumping syndrome, steatorrhea, and vitamin/mineral deficits).
  • Reinforce lifelong follow-up, supplement adherence, and symptom escalation for dehydration, hypoglycemia, or severe GI intolerance.

Stigma and Adherence Risk

Weight-focused judgment can reduce trust and follow-up adherence; use person-centered counseling and shared goal setting.

Pharmacology

Drug ClassExamplesKey Nursing Considerations
lipase-inhibitorsOrlistatTeach fat-distribution strategy, GI-effect management, and fat-soluble vitamin timing.
anorexiantsPhentermine, phentermine-topiramateScreen cardiovascular, mood, seizure, and pregnancy-related contraindications before and during therapy.
bupropion-naltrexone-for-weight-managementNaltrexone-bupropion ERMonitor neuropsychiatric symptoms, BP, seizure risk, and hypoglycemia trend in diabetes.
non-insulin-injectable-diabetes-drugsLiraglutide, semaglutideMonitor GI tolerance and pancreatitis risk; avoid inappropriate duplicate GLP-1 pathway use.
Melanocortin-pathway therapySetmelanotideUse only in selected genetic-obesity pathways with specialist-directed criteria.

Clinical Judgment Application

Clinical Scenario

A patient with BMI 38, hypertension, and type 2 diabetes reports poor sleep, low activity, and repeated short-lived diet attempts.

  • Recognize Cues: Severe obesity with cardiometabolic comorbidity and adherence barriers.
  • Analyze Cues: Risk is driven by clustered physiologic and behavioral factors, not one isolated habit.
  • Prioritize Hypotheses: Sustained lifestyle support with comorbidity-safe pharmacologic planning is the immediate priority.
  • Generate Solutions: Build staged nutrition/activity goals, add structured follow-up, and coordinate obesity-medication evaluation.
  • Take Action: Initiate interdisciplinary plan, reinforce self-monitoring tools, and escalate for medication/surgical candidacy review as indicated.
  • Evaluate Outcomes: Weight trend, activity tolerance, and metabolic markers improve with sustained adherence.

Graph View

Backlinks